当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20207
编号:13499314
输血对胃癌手术患者预后影响的meta分析(4)
http://www.100md.com 2020年3月5日 《中国医药导报》 20207
     [23] An JY,Kim KM,Kim YM,et al. Surgical complications in gastric cancer patients preoperatively treated with chemotherapy:their risk factors and clinical relevance [J]. Ann Surg Oncol,2012,19(8):2452-2458.

    [24] Tsujimoto H,Ichikura T,Ono S,et al. Impact of Postoperative Infection on Long-Term Survival After Potentially Curative Resection for Gastric Cancer [J]. Ann Surg Oncol,2009,16(2):311-318.

    [25] Wang X,Wan F,Pan J,et al. Tumor size:A non-neglectable independent prognostic factor for gastric cancer [J]. J Surg Oncol,2008,97(3):236-240.

    [26] Jung DH,Lee HJ,Han DS,et al. Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery [J]. Gastric Cancer,2013,16(3):377-382.

    [27] Gong DJ,Miao CF,Bao Q,et al. Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy [J]. World J Gastroenterol,2008,14(42):6560.

    [28] Dixon E,Datta I,Sutherland FR,et al. Blood loss in surgical oncology:neglected quality indicator? [J]. J Surg Oncol,2009,99(8):508-512.

    (收稿日期:2019-09-24 本文編辑:王晓晔), 百拇医药(古力帕日·克力木 张蕾)
上一页1 2 3 4